Virus Research At Serbia's Institute of Virology

A laboratory technician injects Influenza A (H1N1) virus into a tray of embryonated hens' eggs during vaccine research work at the Torlak Institute of Virology in Belgrade, Serbia, on Tuesday, March 3, 2020. Coronavirus death rates, estimated at around 2%, are higher than the 0.1% for seasonal flu, another lung infection, but far lower than those from severe acute respiratory syndrome, or SARS, the related virus that killed about 9.6% of some 8,000 people infected. Photographer: Oliver Bunic/Bloomberg via Getty Images
A laboratory technician injects Influenza A (H1N1) virus into a tray of embryonated hens' eggs during vaccine research work at the Torlak Institute of Virology in Belgrade, Serbia, on Tuesday, March 3, 2020. Coronavirus death rates, estimated at around 2%, are higher than the 0.1% for seasonal flu, another lung infection, but far lower than those from severe acute respiratory syndrome, or SARS, the related virus that killed about 9.6% of some 8,000 people infected. Photographer: Oliver Bunic/Bloomberg via Getty Images
Virus Research At Serbia's Institute of Virology
PURCHASE A LICENCE
How can I use this image?
$650.00
AUD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
1205043881
Collection:
Bloomberg
Date created:
04 March, 2020
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
SERBIA VACCINE
Max file size:
4000 x 2889 px (33.87 x 24.46 cm) - 300 dpi - 2 MB